Skip to Main Content

Paper Details

Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program.
Hypertension
2
2021
End-Stage Kidney Disease, Hypertension
Author NameAffiliation
Cassianne Robinson-Cohen
Cassianne Robinson-CohenVanderbilt Center for Kidney Disease (E.A.A.
Cassianne Robinson-CohenTennessee Valley Healthcare System
Shailja C ShahVanderbilt University Medical Center
Shailja C ShahTennessee Valley Healthcare System
Talat Alp Ikizler
Talat Alp IkizlerVanderbilt Center for Kidney Disease (E.A.A.
Talat Alp IkizlerTennessee Valley Healthcare System
Megan M ShueyVanderbilt University Medical Center
Edward D Siew
Edward D SiewVanderbilt Center for Kidney Disease (E.A.A.
Edward D SiewTennessee Valley Healthcare System
Digna R Velez EdwardsVanderbilt University Medical Center
Digna R Velez EdwardsVanderbilt University Medical Center
Digna R Velez EdwardsInstitute of Medicine and Public Health (D.R.V.E., Vanderbilt University Medical Center
Christianne L RoumieVeteran Administration Tennessee Valley VA Health Care System Geriatric Research Education Clinical Center (GRECC)
John Michael GazianoVA Boston Healthcare System
John Michael GazianoBrigham and Women's Hospital, Harvard Medical School
John Michael GazianoVA Boston Healthcare System
John Michael GazianoBrigham and Women's Hospital, Harvard Medical School
Christopher J O'DonnellBrigham and Women's Hospital, Harvard Medical School
Christopher J O'DonnellVA Boston Healthcare System
Christopher J O'DonnellBrigham and Women's Hospital, Harvard Medical School
Christopher J O'DonnellVA Boston Healthcare System
Todd L EdwardsInstitute of Medicine and Public Health (D.R.V.E., Vanderbilt University Medical Center
Todd L EdwardsVanderbilt University Medical Center
Adriana M Hung
Adriana M HungVanderbilt University Medical Center
Adriana M HungVanderbilt Center for Kidney Disease (E.A.A.
Adriana M HungTennessee Valley Healthcare System
  • 1 - 30

Datasets